vs
8X8 INC（EGHT）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是8X8 INC的1.2倍（$219.9M vs $185.1M），8X8 INC净利率更高（2.8% vs -1.0%，领先3.8%），8X8 INC同比增速更快（3.4% vs 2.0%），8X8 INC自由现金流更多（$19.1M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 1.6%）
8x8 Inc是源自美国的企业级云通信与客户体验软件服务商，依托云架构为企业提供统一通信、呼叫中心及通信平台即服务（CPaaS）等产品方案，公司总部位于加利福尼亚州坎贝尔，其股票在纳斯达克交易所挂牌交易。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
EGHT vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.2倍
$185.1M
营收增速更快
EGHT
高出1.5%
2.0%
净利率更高
EGHT
高出3.8%
-1.0%
自由现金流更多
EGHT
多$2.3M
$16.8M
两年增速更快
OFIX
近两年复合增速
1.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $185.1M | $219.9M |
| 净利润 | $5.1M | $-2.2M |
| 毛利率 | 63.9% | 71.1% |
| 营业利润率 | 5.2% | 0.2% |
| 净利率 | 2.8% | -1.0% |
| 营收同比 | 3.4% | 2.0% |
| 净利润同比 | 68.4% | 92.4% |
| 每股收益（稀释后） | $0.04 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EGHTOFIX
| Q4 25 | $185.1M | $219.9M | ||
| Q3 25 | $184.1M | $205.6M | ||
| Q2 25 | $181.4M | $203.1M | ||
| Q1 25 | $177.0M | $193.6M | ||
| Q4 24 | $178.9M | $215.7M | ||
| Q3 24 | $181.0M | $196.6M | ||
| Q2 24 | $178.1M | $198.6M | ||
| Q1 24 | $179.4M | $188.6M |
净利润EGHTOFIX
| Q4 25 | $5.1M | $-2.2M | ||
| Q3 25 | $767.0K | $-22.8M | ||
| Q2 25 | $-4.3M | $-14.1M | ||
| Q1 25 | $-5.4M | $-53.1M | ||
| Q4 24 | $3.0M | $-29.1M | ||
| Q3 24 | $-14.5M | $-27.4M | ||
| Q2 24 | $-10.3M | $-33.4M | ||
| Q1 24 | $-23.6M | $-36.0M |
毛利率EGHTOFIX
| Q4 25 | 63.9% | 71.1% | ||
| Q3 25 | 64.8% | 72.2% | ||
| Q2 25 | 66.4% | 68.7% | ||
| Q1 25 | 67.8% | 62.8% | ||
| Q4 24 | 67.7% | 69.0% | ||
| Q3 24 | 68.1% | 68.7% | ||
| Q2 24 | 67.9% | 67.8% | ||
| Q1 24 | 68.2% | 67.5% |
营业利润率EGHTOFIX
| Q4 25 | 5.2% | 0.2% | ||
| Q3 25 | 2.9% | -8.3% | ||
| Q2 25 | 0.3% | -7.9% | ||
| Q1 25 | 0.2% | -25.2% | ||
| Q4 24 | 5.0% | -5.3% | ||
| Q3 24 | 4.0% | -9.6% | ||
| Q2 24 | -0.8% | -12.5% | ||
| Q1 24 | -7.9% | -15.6% |
净利率EGHTOFIX
| Q4 25 | 2.8% | -1.0% | ||
| Q3 25 | 0.4% | -11.1% | ||
| Q2 25 | -2.4% | -6.9% | ||
| Q1 25 | -3.1% | -27.4% | ||
| Q4 24 | 1.7% | -13.5% | ||
| Q3 24 | -8.0% | -13.9% | ||
| Q2 24 | -5.8% | -16.8% | ||
| Q1 24 | -13.1% | -19.1% |
每股收益（稀释后）EGHTOFIX
| Q4 25 | $0.04 | $-0.05 | ||
| Q3 25 | $0.01 | $-0.57 | ||
| Q2 25 | $-0.03 | $-0.36 | ||
| Q1 25 | $-0.04 | $-1.35 | ||
| Q4 24 | $0.02 | $-0.76 | ||
| Q3 24 | $-0.11 | $-0.71 | ||
| Q2 24 | $-0.08 | $-0.88 | ||
| Q1 24 | $-0.20 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $86.9M | $82.0M |
| 总债务越低越好 | $321.2M | — |
| 股东权益账面价值 | $142.9M | $450.0M |
| 总资产 | $661.5M | $850.6M |
| 负债/权益比越低杠杆越低 | 2.25× | — |
8季度趋势，按日历期对齐
现金及短期投资EGHTOFIX
| Q4 25 | $86.9M | $82.0M | ||
| Q3 25 | $75.9M | $62.9M | ||
| Q2 25 | $81.3M | $65.6M | ||
| Q1 25 | $88.0M | $58.0M | ||
| Q4 24 | $104.2M | $83.2M | ||
| Q3 24 | $117.4M | $30.1M | ||
| Q2 24 | $130.8M | $26.4M | ||
| Q1 24 | $117.3M | $27.0M |
总债务EGHTOFIX
| Q4 25 | $321.2M | — | ||
| Q3 25 | $325.8M | $157.2M | ||
| Q2 25 | $335.4M | $157.0M | ||
| Q1 25 | $350.0M | $156.9M | ||
| Q4 24 | $364.5M | $157.0M | ||
| Q3 24 | $396.9M | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | $409.7M | $118.2M |
股东权益EGHTOFIX
| Q4 25 | $142.9M | $450.0M | ||
| Q3 25 | $133.2M | $442.5M | ||
| Q2 25 | $128.2M | $458.3M | ||
| Q1 25 | $122.2M | $458.3M | ||
| Q4 24 | $113.0M | $503.1M | ||
| Q3 24 | $109.8M | $525.9M | ||
| Q2 24 | $104.6M | $546.0M | ||
| Q1 24 | $102.0M | $570.3M |
总资产EGHTOFIX
| Q4 25 | $661.5M | $850.6M | ||
| Q3 25 | $670.8M | $832.6M | ||
| Q2 25 | $684.3M | $837.2M | ||
| Q1 25 | $683.2M | $823.1M | ||
| Q4 24 | $698.2M | $893.3M | ||
| Q3 24 | $740.1M | $867.9M | ||
| Q2 24 | $755.7M | $882.0M | ||
| Q1 24 | $756.0M | $906.0M |
负债/权益比EGHTOFIX
| Q4 25 | 2.25× | — | ||
| Q3 25 | 2.45× | 0.36× | ||
| Q2 25 | 2.62× | 0.34× | ||
| Q1 25 | 2.86× | 0.34× | ||
| Q4 24 | 3.23× | 0.31× | ||
| Q3 24 | 3.61× | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | 4.02× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.7M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $19.1M | $16.8M |
| 自由现金流率自由现金流/营收 | 10.3% | 7.6% |
| 资本支出强度资本支出/营收 | 0.9% | 4.9% |
| 现金转化率经营现金流/净利润 | 4.07× | — |
| 过去12个月自由现金流最近4个季度 | $43.8M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流EGHTOFIX
| Q4 25 | $20.7M | $27.7M | ||
| Q3 25 | $8.8M | $12.4M | ||
| Q2 25 | $11.9M | $11.6M | ||
| Q1 25 | $5.9M | $-18.4M | ||
| Q4 24 | $27.2M | $23.7M | ||
| Q3 24 | $12.3M | $11.7M | ||
| Q2 24 | $18.1M | $9.0M | ||
| Q1 24 | $12.7M | $-18.6M |
自由现金流EGHTOFIX
| Q4 25 | $19.1M | $16.8M | ||
| Q3 25 | $7.7M | $2.5M | ||
| Q2 25 | $11.5M | $4.5M | ||
| Q1 25 | $5.5M | $-25.1M | ||
| Q4 24 | $26.8M | $15.2M | ||
| Q3 24 | $11.1M | $6.3M | ||
| Q2 24 | $17.8M | $-360.0K | ||
| Q1 24 | $12.3M | $-29.1M |
自由现金流率EGHTOFIX
| Q4 25 | 10.3% | 7.6% | ||
| Q3 25 | 4.2% | 1.2% | ||
| Q2 25 | 6.3% | 2.2% | ||
| Q1 25 | 3.1% | -13.0% | ||
| Q4 24 | 15.0% | 7.0% | ||
| Q3 24 | 6.1% | 3.2% | ||
| Q2 24 | 10.0% | -0.2% | ||
| Q1 24 | 6.9% | -15.4% |
资本支出强度EGHTOFIX
| Q4 25 | 0.9% | 4.9% | ||
| Q3 25 | 0.6% | 4.8% | ||
| Q2 25 | 0.2% | 3.5% | ||
| Q1 25 | 0.2% | 3.5% | ||
| Q4 24 | 0.3% | 4.0% | ||
| Q3 24 | 0.7% | 2.7% | ||
| Q2 24 | 0.2% | 4.7% | ||
| Q1 24 | 0.2% | 5.6% |
现金转化率EGHTOFIX
| Q4 25 | 4.07× | — | ||
| Q3 25 | 11.52× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 9.01× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EGHT
| Services | $179.7M | 97% |
| Other | $5.4M | 3% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
